From: JanD on
http://www.macleans.ca/topstories/health/article.jsp?content=20060123_119825_119825

I wanna be sedated

The insomnia epidemic is now affecting kids

NANCY MACDONALD

Tobin Sheps, a student at Concordia University in Montreal, is trapped in an
awful sleep cycle. It begins innocuously, says the 25-year-old, but quickly
spirals into a pattern of sleepless nights and wrecked days. "It starts by
not falling asleep until 3 a.m., then progresses to 4, 5, 6, until you hit
10 a.m. You force yourself to wake up and go about your day, even if you've
slept for an hour -- or not at all. Somehow you make it through the day,
then you face the same problem when night falls."

Sheps is not alone: one in seven Canadians has trouble falling, or staying,
asleep, according to Statistics Canada. The agency reports that while
insomnia is more prevalent among those with pre-existing health problems
(such as arthritis or asthma), neither disease nor stress is a requisite
factor. Indeed now, as never before, sleeplessness is being considered a
unique disorder, and prescriptions for drugs to combat it have risen as a
result. Some believe this reflects a broader new consumer receptivity to the
medicalization of lifestyle and the use of prescription drugs to enhance
life, abetted, at least in part, by a parallel increase in pharma-marketing.

It's estimated that the global sleep disorder market, whose worth already
tops US$4 billion, will climb to more than $11 billion within a decade.
Currently leading the pharmaceutical pack is Ambien, a prescription medicine
produced by Paris-based Sanofi-Aventis that works by inhibiting the firing
of brain cells and thus lulling the mind to sleep. But in October, Sanofi
will lose its exclusive patent, and consumers' options will increase,
including an offering from the U.S. giant Pfizer, whose ad campaign,
analysts predict, will be of Viagra-like proportions.

Sheps was first prescribed sleeping pills while in junior high. He's been a
"sporadic" user ever since. In fact, it's his demographic that accounts for
much of the increase. The number of young adults under 45 taking sleep aids
in the United States doubled from 2000 to 2004, according to Medco Health
Solutions (an American company that administers prescription drug plans).
Still more dramatic is the increased use by young people aged 10 to 19,
which rose by more than 85 per cent.

These statistics raise myriad concerns. What's not known are the long-term
effects of sleep medication: there are few critical, extended evaluations of
drugs like Ambien. Sleeping pills were conceived as stop-gap measures to
guide patients back to normal circadian rhythms, and drug trials to test
their efficacy and side effects traditionally last six weeks or less. But
some patients use the drugs for months, even years. And though the
medications have been approved for children, their impact on that population
is not known.

Some physicians say that kids have always had trouble getting to sleep and
that, like untying shoelaces, they need to learn how to relax their minds --
perhaps with a bit of parental prodding. "A big part is behaviour and
behaviour management," says Dr. David F. Smith, medical director of the
general pediatric clinic at the B.C. Children's Hospital in Vancouver. "In
practice I see a lot of kids who end up with a sleep debt simply because
their parents don't put them to bed and insist they stay in their bedroom."

For some young people, it's no more complicated than learning to block the
barrage of stimulants like video games, cellphones and instant messaging.
But others are kept awake by the powerful drugs that combat attention
deficit and hyperactivity disorder (ADHD). About 15 per cent of children
prescribed sleep aids are also taking pills to combat ADHD, according to
Medco. Sheps, too, uses sleeping pills to counteract his Ritalin -- meaning
he, like many kids and young adults, is taking stimulants by day and
depressants by night.

For some parents, it's worth the risk: aside from the obvious psychological
damage brought on by chronic insomnia, studies suggest that it can
contribute to a host of other illnesses. The Harvard Women's Health Watch
recently linked sleep deprivation to weight gain and hypertension, and noted
that it can decrease the immune system's ability to ward off illness.
Sleeplessness has also been cited as a trigger for depression. What's more,
a recent study by Princeton psychologist and Nobel laureate, Daniel
Kahneman, found that happiness is affected by the quality of people's
sleep -- more than by any other factor, including income.

Drug companies are not the only ones cashing in on the insomnia epidemic.
For makers of mattresses and bedding, it also spells opportunity, and has
created a new growth industry -- with products such as "memory foam"
mattresses and sweat-wicking pillows. But more and more of the
sleep-deprived are opting for a sure thing -- medication -- and are quite
content to hop into bed each night with Big Pharma.